Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis. 2011;52:219–27.

Article  PubMed  PubMed Central  Google Scholar 

Harboe ZB, Larsen MV, Ladelund S, Kronborg G, Konradsen HB, Gerstoft J, et al. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users. Clin Infect Dis. 2014;59:1168–76.

Article  CAS  PubMed  Google Scholar 

CDC. 2019, https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/specific-groups.html.

Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48:787–94.

Article  PubMed  Google Scholar 

Gazzola L, Tincati C, Bellistri GM, Monforte A, Marchetti G. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options. Clin Infect Dis. 2009;48:328–37.

Article  PubMed  Google Scholar 

El Chaer F, El, Sahly HM. Vaccination in the adult patient infected with HIV: a review of vaccine efficacy and immunogenicity. Am J Med. 2019;132:437–46.

Article  PubMed  Google Scholar 

Kerneis S, Launay O, Turbelin C, Batteux F, Hanslik T, Boelle PY. Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. Clin Infect Dis. 2014;58:1130–9.

Article  PubMed  Google Scholar 

WHO. HIV, Estimated number of people (all ages) living with HIV. 2021, https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-number-of-people-living-with-hiv.

Sachdev D, Mara E, Hsu L, Scheer S, Rutherford G, Enanoria W, et al. COVID-19 susceptibility and outcomes among people living with HIV in San Francisco. J Acquir Immune Defic Syndr. 2021;86:19–21.

Article  CAS  PubMed  Google Scholar 

Inciarte A, Gonzalez-Cordon A, Rojas J, Torres B, de Lazzari E, de la Mora L, et al. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS. 2020;34:1775–80.

Article  CAS  PubMed  Google Scholar 

Del Amo J, Polo R, Moreno S, Diaz A, Martinez E, Arribas JR, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy : a cohort study. Ann Intern Med. 2020;173:536–41.

Article  PubMed  Google Scholar 

Charre C, Icard V, Pradat P, Brochier C, Lina B, Chidiac C, et al. Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis users. AIDS. 2020;34:1765–70.

Article  CAS  PubMed  Google Scholar 

Huang J, Xie N, Hu X, Yan H, Ding J, Liu P, et al. Epidemiological, virological and serological features of Coronavirus Disease 2019 (COVID-19) cases in people living with human immunodeficiency virus in Wuhan: a population-based cohort study. Clin Infect Dis. 2021;73:e2086–94.

Article  CAS  PubMed  Google Scholar 

Park LS, McGinnis KA, Gordon KS, Justice AC, Leyden W, Silverberg MJ, et al. SARS-CoV-2 testing and positivity among persons with and without HIV in 6 US cohorts. J Acquir Immune Defic Syndr. 2022;90:249–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Xie Y, Hu S, Ai W, Tao Y, Tang H, et al. Systematic review and meta-analyses of the interaction between HIV infection and COVID-19: two years’ evidence summary. Front Immunol. 2022;13:864838.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med. 2020;8:659–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okoye AA, Picker LJ. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev. 2013;254:54–64.

Article  PubMed  PubMed Central  Google Scholar 

Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses. 2019;11:200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanson HA, Kim E, Badowski ME. A systematic review: impact of SARS-CoV-2 infection on morbidity, mortality, and viral suppression in patients living with HIV. SN Compr Clin Med. 2023;5:144.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang X, Sun J, Patel RC, Zhang J, Guo S, Zheng Q, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021;8:e690–700.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clin Infect Dis. 2021;73:e1964–72.

Article  CAS  PubMed  Google Scholar 

Tesoriero JM, Swain CE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York state. JAMA Netw Open. 2021;4:e2037069.

Article  PubMed  PubMed Central  Google Scholar 

Kassanjee R, Davies MA, Ngwenya O, Osei-Yeboah R, Jacobs T, Morden E, et al. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa. J Int AIDS Soc. 2023;26:e26104.

Article  PubMed  PubMed Central  Google Scholar 

Wit FW, Reiss P, Rijnders B, Rokx C, Roukens A, Brinkman K, et al. COVID-19 in people with HIV in the Netherlands, the ATHENA cohort study. AIDS. 2023;37:1671–81.

Nomah DK, Reyes-Uruena J, Diaz Y, Moreno S, Aceiton J, Bruguera A, et al. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021;8:e701–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel VV, Felsen UR, Fisher M, Fazzari MJ, Ginsberg MS, Beil R, et al. Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2021;86:224–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yendewa GA, Perez JA, Schlick K, Tribout H, McComsey GA. Clinical features and outcomes of coronavirus disease 2019 among people with human immunodeficiency virus in the United States: a multicenter study from a large global health research network (TriNetX). Open Forum Infect Dis. 2021;8:ofab272.

Article  PubMed  PubMed Central  Google Scholar 

Favara G, Barchitta M, Maugeri A, Faro G, Agodi A. HIV infection does not affect the risk of death of COVID-19 patients: a systematic review and meta-analysis of epidemiological studies. J Glob Health. 2022;12:05036.

Article  PubMed  PubMed Central  Google Scholar 

Möller IK, Gisslén M, Wagner P, Sparén P, Carlander C. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study. HIV Med. 2023. https://doi.org/10.1111/hiv.13515. Online ahead of print.

Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, et al. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19. Lancet HIV. 2022;9:e486–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases SA. Risk factors for Coronavirus Disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province. South Afr Clin Infect Dis. 2021;73:e2005–15.

Article  Google Scholar 

Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Clin Infect Dis. 2011;53:1127–9.

Article  PubMed  Google Scholar 

Bloomfield GS, Khazanie P, Morris A, Rabadan-Diehl C, Benjamin LA, Murdoch D, et al. HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research. J Acquir Immune Defic Syndr. 2014;67:S40–53.

Article  PubMed  PubMed Central  Google Scholar 

Hernandez-Romieu AC, Garg S, Rosenberg ES, Thompson-Paul AM, Skarbinski J. Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010. BMJ Open Diabetes Res Care. 2017;5:e000304.

Article  PubMed  PubMed Central  Google Scholar 

Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association. Circulation. 2019;140:e98–124.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. 2023;29:334–43.

Article  CAS  PubMed  Google Scholar 

Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci. 2020;253:117592.

Article  CAS  PubMed  PubMed Central